CellSystems® will be participating in this year’s 50. Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung e. V., ADF
Explore our latest products & services. We look forward to engaging with you at ADF and providing insights into our innovative solutions for dermatology research.
See you at our booth!
We significantly broadened the portfolio of human Mononuclear Cells (MNCs) and isolated hematopoietic cell types from
We now offer specific subsets of T cells, B cells, NK cells and monocytes isolated by positive selection of target cells or by depletion of non-target cells. Furthermore, CD34+ Hematopoietic Stem Cells as well as the CD34– cells (cell fraction depleted of CD34+ cells) are available from several sources, also as “matched sets” from the same donor.
Furthermore, we also offer a wide variety of cells differentiated from induced Pluripotent Stem Cells (iPSCs). The ready-to-use hematopoietic iPSC-derived cells come with optimized medium for most reliable results.
Have a look on the table about available Hematopoietic Celltypes and Sources.
Click on the following links for a complete list of available human Primary Cells as well as ready-to-use iPSC-derived cells.
Collagen is the most abundant protein in the body and is thus the most widely used ECM protein in research across hundreds of various assays.
PureCol® Type I Collagen is the most popular collagen product, being 3 mg/ml of type I atelocollagen (>99.9% pure), and is the product referenced in each of the assays below. Other ABM Collagen products may be substituted in these assays if different mechanical properties of the collagen are desired (ie. use Telocollagen for stiffer hydrogels to evaluate changes in migration related to stiffness). Descriptions of some of the assays are found below the chart.
(published 01/26/23: Advanced BioMatrix – 26 Assays Using PureCol Collagen)
After a long time with very limited opportunities to meet our highly valued customers in person, we are now looking forward to meeting you again.
Come by our booth at
– 49. ADF-Tagung, 22 – 25 February 2023, Innsbruck, Austria
– 3D Cell Culture 2023, 17 – 19 April 2023, Freiburg, Germany
and don’t miss out on information about new and relevant products & services for your research area of interest.
We are hoping to see you there!
Your CellSystems Team
“Giving Up is Not an Option”
On June 2, 2022, Katharina, daughter of our scientific sales representative Monika Kleu, took part in the “Alpe d’HuZes” – a remarkable sporting event dedicated to raising funds for cancer research and improving the lives of those affected by cancer.
“Giving Up is not an Option” was the powerful motto of this event and also the rallying cry of Katharina’s team, the Bee Team, led by Gerdi Poelstra-Luurs, who proved themselves to be a true “A-Team”. The team, embodying remarkable perseverance and spirit, successfully tackled the 21 hairpin bends of the challenging 15 km route through the Alps.
As proud sponsors, CellSystems GmbH was thrilled to support this initiative, contributing to the impressive total raised for such a crucial cause.
Our heartfelt congratulations go out to the Bee Team!
CellSystems offers products for enzymatic cell dissociation (Laborjournal 1-2/2022; link).
Additional enzymes for cell dissociation:
CellSystems offers products for 3D cell culture applications (link)
Our annual Quality Management System audit took place at 12.05.2021.
Thank you to all participants for a successful audit.
General Manager: Markus Gemein
Now avaiable:
Glucose-6-Phosphate Dehydrogenase, High-Activity, Suspension
Chromatographically purified for higher specific activity. Same as Code: ZF except assayed using NAD. Phosphohexose isomerase, phosphogluconate dehydrogenase, adenylate kinase and creatine phosphokinase contaminant activities 0.02 %, 0.003 %, 0.002 % and 0.002 % respectively. A suspension in 3.7 M ammonium sulfate.
Activity: ≥ 600 NAD units per mg protein
Unit Definition: One Unit reduces one micromole of NAD per minute at 30 °C, pH 7.8, using glucose-6-phosphate as substrate.
Bulk requests – contact us
Applied StemCell’s (ASC) TARGATT™ technology allows site-specific, irreversible gene insertion (up to 20 kb). ASC has taken its proprietary knockin technology and integrated the system into CHO and HEK293 cells. The TARGATT™ CHO and HEK293 Master Cell Lines have displayed high integration efficiencies and medium to high levels of protein expression. These cell lines have the potential to be used for bioproduction, to establish a mammalian cell-based library for antibody screening, and to construct a naïve IgG library system.